The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study

AIMS: Galectin‐3 (Gal‐3) predicts long‐term outcome among patients with heart failure (HF) with preserved ejection fraction (HFpEF). The ability of Gal‐3 to diagnose and predict incident HFpEF in a cohort at risk for HFpEF is of particular interest. We aimed to determine the association between Gal‐...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Trippel, Tobias Daniel, Mende, Meinhard, Düngen, Hans‐Dirk, Hashemi, Djawid, Petutschnigg, Johannes, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Binder, Lutz, Hasenfuss, Gerd, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006663/
https://ncbi.nlm.nih.gov/pubmed/33566456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13174
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars